Correlation Between Eli Lilly and Tevogen Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Tevogen Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Tevogen Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Tevogen Bio Holdings, you can compare the effects of market volatilities on Eli Lilly and Tevogen Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Tevogen Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Tevogen Bio.

Diversification Opportunities for Eli Lilly and Tevogen Bio

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Eli and Tevogen is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Tevogen Bio Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tevogen Bio Holdings and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Tevogen Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tevogen Bio Holdings has no effect on the direction of Eli Lilly i.e., Eli Lilly and Tevogen Bio go up and down completely randomly.

Pair Corralation between Eli Lilly and Tevogen Bio

Considering the 90-day investment horizon Eli Lilly and is expected to generate 0.3 times more return on investment than Tevogen Bio. However, Eli Lilly and is 3.34 times less risky than Tevogen Bio. It trades about -0.08 of its potential returns per unit of risk. Tevogen Bio Holdings is currently generating about -0.39 per unit of risk. If you would invest  81,751  in Eli Lilly and on September 13, 2024 and sell it today you would lose (3,294) from holding Eli Lilly and or give up 4.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

Eli Lilly and  vs.  Tevogen Bio Holdings

 Performance 
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of sluggish performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Tevogen Bio Holdings 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tevogen Bio Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal technical and fundamental indicators, Tevogen Bio displayed solid returns over the last few months and may actually be approaching a breakup point.

Eli Lilly and Tevogen Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eli Lilly and Tevogen Bio

The main advantage of trading using opposite Eli Lilly and Tevogen Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Tevogen Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tevogen Bio will offset losses from the drop in Tevogen Bio's long position.
The idea behind Eli Lilly and and Tevogen Bio Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.